Short-term trial of etanercept in Behcet's disease: A double blind, placebo controlled study


Melikoglu M. , Fresko I. , Mat C., Ozyazgan Y. , Gogus F., Yurdakul S. , ...Daha Fazla

JOURNAL OF RHEUMATOLOGY, cilt.32, ss.98-105, 2005 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 32 Konu: 1
  • Basım Tarihi: 2005
  • Dergi Adı: JOURNAL OF RHEUMATOLOGY
  • Sayfa Sayıları: ss.98-105

Özet

Objective. To determine the effect of the tumor necrosis factor-a blocker-etanercept on the pathergy and monosodium urate (MSU) status and on the mucocutaneous and articular manifestations of patients with Behcet's disease (BD).